Concepedia

Emma Johnson

EJ

Statistics

Publications

6

Citations

668

H-Index

6

Active since

2013

Affiliations

Cancer Research UK Scotland Institute(Current)

University of Glasgow

Institute of Cancer Research

Newcastle upon Tyne Hospitals NHS Foundation Trust

University of Cambridge

Emma Johnson is an author at Cancer Research UK Scotland Institute specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2013–2025

6

Publications

6

The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer

Arafath K. Najumudeen, Fatih Ceteci, Sigrid K. Fey et al. · Nature Genetics · 2021 · 329 citations · Full text

, , +12

MCL-1 is a prognostic indicator and drug target in breast cancer

Kirsteen J. Campbell, Sandeep Dhayade, Nicola Ferrari et al. · Cell Death and Disease · 2018 · 203 citations · Full text

, , +17

A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors

Malini Menon, Richard Elliott, Leandra Bowers et al. · Scientific Reports · 2019 · 61 citations · Full text

, , +16

Neutropenic sepsis: prevention and management of neutropenic sepsis in cancer patients (NICE Clinical Guideline CG151)

Jessica Bate, Faith Gibson, Emma Johnson et al. · Archives of Disease in Childhood Education & Practice · 2013 · 29 citations · Full text

, , +16

Human-correlated genetic models identify precision therapy for liver cancer

Miryam Müller, Stephanie May, H. G. HALL et al. · Nature · 2025 · 25 citations · Full text

, , +16

1–5 of 6